Help - Search - Members - Calendar
Full Version: Chronic-Obstructive-Pulmonary
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Respiratory > Chronic-Obstructive-Pulmonary
Pages: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
  1. COPD: African-americans have unique lung cancer risks from chronic obstructive pulmonary disease (0 replies)
  2. COPD: Pharmacists reduce hospital visits for patients with chronic obstructive pulmonary disease (0 replies)
  3. COPD: Orexo initiates clinical phase ii program for ox914 - a new product candidate for the treatment of inflammatory airway diseases (0 replies)
  4. COPD: The airway response to deep inspirations decreases with copd severity and is associated with airway distensibility assessed by computed tomography (0 replies)
  5. COPD: Altered metabolic and transporter characteristics of vastus lateralis in chronic obstructive pulmonary disease (0 replies)
  6. COPD: Nrf2-associated antioxidant levels inversely linked to copd severity (0 replies)
  7. COPD: Copd increases risk for lung cancer in african americans (0 replies)
  8. COPD: African-american copd links to lung cancer (0 replies)
  9. COPD: Lung cancer risk high in african americans with respiratory disease (0 replies)
  10. COPD: Lung cancer risk prediction differs by race (0 replies)
  11. COPD: Telehealth monitoring for copd patients (0 replies)
  12. COPD: African americans have unique lung cancer risks from chronic obstructive pulmonary disease (0 replies)
  13. COPD: African-americans have lung cancer risks from chronic obstructive pulmonary disease (0 replies)
  14. COPD: African-americans have unique lung cancer risks from chronic obstructive pulmonary disease (0 replies)
  15. COPD: Mutation of murine adenylate kinase 7 underlies a primary ciliary dyskinesia phenotype. (0 replies)
  16. COPD: Breathing disorder puts blacks at high cancer risk (0 replies)
  17. COPD: Phase iii clinical studies of aclidinium bromide show statistical significance vs. placebo in patients with chronic obstructive pulmonary disease (0 replies)
  18. COPD: Organization of metabolic pathways in vastus lateralis of patients with chronic obstructive pulmonary disease (0 replies)
  19. COPD: Copd patients do not benefit from therapy for pulmonary hypertension (0 replies)
  20. COPD: Phase iii clinical studies of aclidinium bromide show statistical significance vs. placebo in patients with chronic obstructive pulmonary disease (copd) (0 replies)
  21. COPD: Cell-phone coaching system shows potential for copd patients (0 replies)
  22. COPD: Unrecognized myocardical infarctions common in patients with copd (0 replies)
  23. COPD: Depression and anxiety linked to increased lung disease attacks (0 replies)
  24. COPD: Statin therapy effectively reduces mortality among patients with copd (0 replies)
  25. COPD: Stereotactic body radiotherapy for medically inoperable patients with stage i non-small cell lung cancer - a first report of toxicity related to copd/cvd in a non-randomized prospective phase ii study. (0 replies)
  26. COPD: Catastrophic graft-versus-host disease after lung transplantation proven by pcr-based chimerism analysis (0 replies)
  27. COPD: The patients assessment chronic illness care (pacic) questionnaire in the netherlands: a validation study in rural general practice (0 replies)
  28. COPD: Cardiovascular magnetic resonance imaging to identify left-sided chronic heart failure in stable patients with chronic obstructive pulmonary disease. (0 replies)
  29. COPD: Estimating maximum work rate during incremental cycle ergometry testing from six-minute walk distance in patients with chronic obstructive pulmonary disease. (0 replies)
  30. COPD: Defective antioxidant gene regulation in copd: a case for broccoli. (0 replies)
  31. COPD: Reconstruction of large post-sternotomy wound with bilateral "v-y fasciocutaneous advancement flaps". (0 replies)
  32. COPD: Copd as a systemic disease: impact on physical functional limitations. (0 replies)
  33. COPD: Lung function response to 12-week treatment with combined inhalation of long-acting β2 agonist and glucocorticoid according to
    adrb2
    polymorphism in patients with chronic obstructive pulmonary disease     (0 replies)
  34. COPD: A single session of acu-tens increases fev1 and reduces dyspnoea in patients with chronic obstructive pulmonary disease: a randomised, placebo-controlled trial. (0 replies)
  35. COPD: Statin therapy effectively reduces mortality among patients with copd,. (0 replies)
  36. COPD: Florida is state with highest percentage of untreated patients with chronic obstructive pulmonary disease (0 replies)
  37. COPD: What defines abnormal lung function in older adults with chronic obstructive pulmonary disease? (0 replies)
  38. COPD: Carbon ion radiotherapy for elderly patients 80 years and older with stage i non-small cell lung cancer. (0 replies)
  39. COPD: Med sci monit 2008; 14(9):cr485-492 "capnometry in spontaneously breathing patients: the influence of chronic obstructive pulmonary disease and expiration maneuvers" (0 replies)
  40. COPD: Med sci monit 2008; 14(9):mt27-35 "serological diagnosis of chlamydophila pneumoniae infection in greek copd patients by microimmunofluorescence and elisa" (0 replies)
  41. COPD: Is it possible to reduce the use of antibiotics in severe exacerbations of copd? (0 replies)
  42. COPD: Factors predicting bacterial involvement in severe acute exacerbations of chronic obstructive pulmonary disease (0 replies)
  43. COPD: Relationship of metabolic alkalosis, azotemia and morbidity in patients with chronic obstructive pulmonary disease and hypercapnia (0 replies)
  44. COPD: Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study (0 replies)
  45. COPD: Chronic obstructive pulmonary disease and home rehabilitation - the mobile phone's crucial role (0 replies)
  46. COPD: Acute oxygen therapy does not improve cognitive and driving performance in hypoxaemic copd (0 replies)
  47. COPD: Determinants of subjective sleepiness in suspected obstructive sleep apnoea (0 replies)
  48. COPD: Unrecognised heart attacks common in patients with lung disease (0 replies)
  49. COPD: What defines abnormal lung function in older adults with chronic obstructive pulmonary disease? (0 replies)
  50. COPD: Swindon pct launches mainstream telehealth monitoring service for copd patients (0 replies)
  51. COPD: The cftr m470v gene variant as a potential modifier of copd severity: study of serbian population (0 replies)
  52. COPD: Age does not hamper the response to pulmonary rehabilitation of copd patients (0 replies)
  53. COPD: Thyme extract, but not thymol, inhibits endothelin-induced contractions of isolated rat trachea (0 replies)
  54. COPD: Lack of pulmonary rehab a 'serious problem' (0 replies)
  55. COPD: [case reports] reconstruction of large post-sternotomy wound with bilateral "v-y fasciocutaneous advancement flaps" (0 replies)
  56. COPD: Potential role of leukotriene modifiers in the treatment of chronic obstructive pulmonary disease (0 replies)
  57. COPD: Perceptual and physiological responses during treadmill and cycle exercise in patients with copd. (0 replies)
  58. COPD: Proteomic analysis in lung tissue of smokers and chronic obstructive pulmonary disease patients. (0 replies)
  59. COPD: Determinants of subjective sleepiness in suspected obstructive sleep apnoea. (0 replies)
  60. COPD: Creatine supplements do not improve strength in lung disease patients (0 replies)
  61. COPD: [editorials] copd, diagrams and traditions: time to move on? (0 replies)
  62. COPD: [editorials] what evidence could validate the definition of copd? (0 replies)
  63. COPD: [chronic obstructive pulmonary disease] proportional classifications of copd phenotypes (0 replies)
  64. COPD: [miscellaneous] "prognostic pessimism" in asthma and copd (0 replies)
  65. COPD: [chronic obstructive pulmonary disease] long-term decline in lung function, utilisation of care and quality of life in modified gold stage 1 copd (0 replies)
  66. COPD: [chronic obstructive pulmonary disease] minimum clinically important improvement for the incremental shuttle walking test (0 replies)
  67. COPD: [respiratory infection] incidence and predictive factors of lower respiratory tract infections among the very elderly in the general population. the leiden 85-plus study (0 replies)
  68. COPD: [miscellaneous] lung transplantation in patients with copd (0 replies)
  69. COPD: [review] patient adherence in copd (0 replies)
  70. COPD: A comparison of health-care costs in patients with chronic obstructive pulmonary disease using lightweight portable oxygen systems versus traditional compressed-oxygen systems. (0 replies)
  71. COPD: A brief history of pulmonary rehabilitation. (0 replies)
  72. COPD: The roles of bronchodilators, supplemental oxygen, and ventilatory assistance in the pulmonary rehabilitation of patients with chronic obstructive pulmonary disease. (0 replies)
  73. COPD: Pulmonary rehabilitation: summary of an evidence-based guideline. (0 replies)
  74. COPD: Salmeterol/fluticasone propionate slows copd progression. (0 replies)
  75. COPD: Common infection may increase risk for copd (0 replies)
  76. COPD: Inhalation of staphylococcus aureus enterotoxin a induces ifn-{gamma} and cd8 t cell-dependent airway and interstitial lung pathology in mice. (0 replies)
  77. COPD: Accuracy of uniaxial accelerometer in chronic obstructive pulmonary disease. (0 replies)
  78. COPD: Advanced chronic obstructive pulmonary disease: rethinking models of care (0 replies)
  79. COPD: Cd8 chemokine receptors in chronic obstructive pulmonary disease (0 replies)
  80. COPD: Multidimensional index reliable surrogate of copd survival (0 replies)
  81. COPD: Chronic obstructive pulmonary disease: a view from the nhlbi. (0 replies)
  82. COPD: Lung's protective response against tobacco smoke blocked by infection (0 replies)
  83. COPD: The possible role of hematopoietic cell kinase in the pathophysiology of chronic obstructive pulmonary disease. (0 replies)
  84. COPD: Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy controls, healthy smokers and copd patients. (0 replies)
  85. COPD: Occupational history quality in patients with newly documented, clinician diagnosed chronic bronchitis. (0 replies)
  86. COPD: Combination therapy reduces copd exacerbations (0 replies)
  87. COPD: Infection blocks lung's protective response against tobacco smoke (0 replies)
  88. COPD: Nip award news - breathing easier in blackburn (0 replies)
  89. COPD: Airway dimensions at inspiratory and expiratory multisection ct in chronic obstructive pulmonary disease: correlation with airflow limitation. (0 replies)
  90. COPD: Infection may increase lung disease risk in smokers (0 replies)
  91. COPD: Infection blocks lung's protective response against tobacco smoke (0 replies)
  92. COPD: Editorial: preventing ventilator-associated pneumonia: could silver-coated endotracheal tubes be the answer? (0 replies)
  93. COPD: Hope for patients with copd (0 replies)
  94. COPD: Gender differences in correlations between the content of elements in rain water and the frequency of hospitalization for arterial hypertension, chronic obstructive pulmonary disease, and psoriasis in opole voivodship, poland, during 2000-2002. (0 replies)
  95. COPD: Drugs may slow decline in lungs of copd patients (0 replies)
  96. COPD: Drugs slow copd progression (0 replies)
  97. COPD: Salmeterol plus fluticasone slows disease progression in moderate to severe copd (0 replies)
  98. COPD: Combination therapy slows lung function decline in copd patients (0 replies)
  99. COPD: Combination therapy slows lung function decline in copd patients (0 replies)
  100. COPD: Inhalers slow copd lung-function loss (0 replies)
  101. COPD: Hope for patients with copd (0 replies)
  102. COPD: Is herniosis the single etiology of saint’s triad? (0 replies)
  103. COPD: Time-dependent confounding in the study of the effects of regular physical activity in chronic obstructive pulmonary disease: an application of the marginal structural model. (0 replies)
  104. COPD: Hope for patients with copd (0 replies)
  105. COPD: Weather alerts benefit copd patients (0 replies)
  106. COPD: Occupational exposure to dust, fumes, and vapors can double copd risk (0 replies)
  107. COPD: Pharmacologic stress testing: a new selective vasodilator (0 replies)
  108. COPD: Intrinsic and synaptic long-term depression of nts relay of nociceptin- and capsaicin-sensitive cardiopulmonary afferents hyperactivity. (0 replies)
  109. COPD: Foxp3-positive t cell numbers altered in copd (0 replies)
  110. COPD: Start of phase 2b right-heart catheter study of prx-08066 in patients with chronic obstructive pulmonary disease and moderate-to-severe ph (0 replies)
  111. COPD: Discriminative and predictive properties of disease-specific and generic health status indexes in elderly copd patients (0 replies)
  112. COPD: Automated copd warnings cut hospital admissions (0 replies)
  113. COPD: Weather alert scheme benefits uk lung disease patients (0 replies)
  114. COPD: Use of controller medications in patients initiated on a long-acting beta2-adrenergic agonist before and after safety alerts. (0 replies)
  115. COPD: Asthma in older adults satellite broadcast program, australia (0 replies)
  116. COPD: Noninvasive ventilation as ceiling of therapy in end-stage chronic obstructive pulmonary disease (0 replies)
  117. COPD: Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (slpi) by lung epithelial cells: role of charge of the proteinase-inhibitor complex (0 replies)
  118. COPD: Combination treatment slows lung function decline in copd (0 replies)
  119. COPD: Workplace substance exposure increases lung disease risk (0 replies)
  120. COPD: Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease (0 replies)
  121. COPD: Biota holdings limited (asx:bta) commences human rhinovirus phase iia clinical trial (0 replies)
  122. COPD: Weather alerts reduce copd hospital admissions in uk (0 replies)
  123. COPD: Long-term programs needed to change activity patterns of copd patients (0 replies)
  124. COPD: Enhanced levels of prostaglandin e2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable copd (0 replies)
  125. COPD: Risk factors and outcome of community-acquired pneumonia due to gram-negative bacilli (0 replies)
  126. COPD: Altered expression of antimicrobial molecules in cigarette smoke-exposed emphysematous mice lungs (0 replies)
  127. COPD: Eligibility criteria in heart failure randomized controlled trials: a gap between evidence and clinical practice (0 replies)
  128. COPD: Impact of occupational exposure on severity of chronic obstructive pulmonary disease. (0 replies)
  129. COPD: Relationship between gastroesophageal reflux disease and copd in uk primary care. (0 replies)
  130. COPD: The risk for depression comorbidity in patients with copd. (0 replies)
  131. COPD: Differences in hospital mortality among critically ill patients of asian, native indian and european descent. (0 replies)
  132. COPD: Chronic obstructive pulmonary disease prevalence in southeastern kentucky: the burden of lung disease study. (0 replies)
  133. COPD: Hypnotic use for insomnia management in chronic obstructive pulmonary disease. (0 replies)
  134. COPD: Viral infections increase exacerbations in copd patients (0 replies)
  135. COPD: Antibiotics combat copd exacerbations (0 replies)
  136. COPD: For easier breathing (0 replies)
  137. COPD: Initial validation of the argentinean spanish version of the pedsqltm 4.0 generic core scales in children and adolescents with chronic diseases: acceptability and comprehensibility in low-income settings (0 replies)
  138. COPD: Relb is differentially regulated by i{kappa}b-kinase{alpha} (ikk{alpha}) in b cells and mouse lung by cigarette smoke. (0 replies)
  139. COPD: For easier breathing (0 replies)
  140. COPD: Higher skeletal muscular metabolic reserve capacity in copd patients than healthy subjects (0 replies)
  141. COPD: Abnormal sarcoplasmic reticulum ca2+-sequestering properties in skeletal muscle in chronic obstructive pulmonary disease (0 replies)
  142. COPD: Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans (0 replies)
  143. COPD: Viral infections linked to exacerbations in lung disease patients (0 replies)
  144. COPD: Antibiotics may reduce symptom attacks in lung disease patients (0 replies)
  145. COPD: Medications to modify lung function decline in chronic obstructive pulmonary disease: some hopeful signs. (0 replies)
  146. COPD: A unique spirometric phenotype in copd. (0 replies)
  147. COPD: The considerable, often neglected, impact of pulmonary tuberculosis on the prevalence of copd. (0 replies)
  148. COPD: A national study of chronic disease prevalence and access to care in uninsured u.s. adults. (0 replies)
  149. COPD: Creatine a bust for boosting exercise benefit in copd (0 replies)
  150. COPD: Creatine has negligible effect on copd exercise rehab (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2008 Invision Power Services, Inc.